Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...

Researchers have created a way to guide and control the development of stem cells into specific tissues and organs, opening the door to developing a means of one day tackling complex diseases like ...

While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell ...

MSCs are isolated from the bone marrow of healthy adult human donors and are used to treat SR-aGVHD in patients who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT).

Renowned visionary English physician William Harvey wrote in 1651 about how our blood contains all the secrets of life. "And so I conclude that blood lives and is nourished of itself and in no way ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Rio and colleagues' open ...

3 Allogeneic HSCT has been reported to be feasible and effective in the short term and medium term (ie, 6 months to 3 years), with donors being HLA-identical siblings (most cases), a haplo-identical ...

Andrew Cassy had spent his working life in a telecommunications research department until a diagnosis of Parkinson’s disease in 2010 pushed him into early retirement. Curious about his illness ...

1 Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China 2 Beijing Key Laboratory of Diabetes Research and Care, Beijing, China ...

A phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and feasibility of neural stem cell transplantation for ...

The study, published in the December 17 edition of Cell Reports Medicine, was led by Joseph Ciacci, M.D., a professor in the Department of Neurological Surgery at UC San Diego School of Medicine ...